Allopurinol Tablet
Product Images NDC 51655-782

Product Visual Gallery

This gallery contains 3 technical images submitted to the FDA as part of the official labeling for Allopurinol (NDC 51655-782). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Northwind Health Company, Llc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Label (51655 782 52 Master Bottle Label Approval Rev A 08 21)

Label for Allopurinol Tablets USP 300 mg, containing 30 tablets in the package. The label includes storage instructions to keep the product at 15°-30°C (59°-86°F), out of reach of children, in the original container and protected from moisture. Distributed by Northwind Pharmaceuticals and repackaged by Dr. Reddy's Laboratories Louisiana, LLC.*

FDA Label Image

Structure (Structure)

Chemical structure of allopurinol, the active ingredient in the Allopurinol 300 mg oral tablet by Northwind Health Company, LLC.*

FDA Label Image

Structure2 (Structure2)

Chemical structure diagram showing the transformation pathway among purine derivatives including Allopurinol, Oxipurinol, Hypoxanthine, Xanthine, and Uric Acid with chemical names and molecular structures.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.